<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2870">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    https://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 13, 2016</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01469234</url>
  </required_header>
  <id_info>
    <org_study_id>18126</org_study_id>
    <secondary_id>PT11-37</secondary_id>
    <secondary_id>P08712</secondary_id>
    <nct_id>NCT01469234</nct_id>
  </id_info>
  <brief_title>A Study of Onset of Action of Loratadine and Fexofenadine in Participants With Seasonal Allergic Rhinitis (P08712)</brief_title>
  <official_title>A Double-Blind, Parallel, Randomized, Placebo Controlled Trial to Evaluate Onset of Action of Loratadine and Fexofenadine in Subjects With Seasonal Allergic Rhinitis in a Pollen Challenge Chamber</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bayer</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bayer</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the onset of action of two commercially available
      over-the-counter antihistamines (Loratadine and

      Fexofenadine) in a model of seasonal allergic rhinitis (SAR). Participants undergo
      sensitization exposures to Mountain Cedar (juniperus ashei) pollen in a Biogenics Research
      Chamber; those who demonstrate an adequate allergic response determined by the Major Symptom
      Complex (MSC) score will then receive drug.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2011</start_date>
  <completion_date type="Actual">November 2011</completion_date>
  <primary_completion_date type="Actual">November 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Mean Major Symptom Complex (MSC) Score by Post-Treatment Evaluation Time Point (From 180 Minutes to 300 Minutes)</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The MSC Score is calculated as the sum of 5 individual symptom scores for Runny Nose, Itchy Nose, Sneezing, Watery Eyes, and Itchy Eyes. Each individual symptom is rated on a 5-point scale of severity: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The total MSC score ranges from 0 - 25. Increasing scores are associated with increasing severity.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Score for Runny Nose by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Runny Nose was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Runny Nose symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Score for Itchy Nose by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Itchy Nose was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Nose symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Scores for Sneezing by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Sneezing was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Sneezing symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Scores for Watery Eyes by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Water Eyes was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Watery Eyes symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Scores for Itchy Eyes by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Itchy Eyes was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Eyes symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Scores for Nasal Congestion by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Nasal Congestion was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Nasal Congestion symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean Individual Symptom Scores for Itchy Mouth/Throat/Ears by Post-Treatment Evaluation Time Point</measure>
    <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
    <safety_issue>No</safety_issue>
    <description>The individual symptom score for Itchy Mouth/Throat/Ears was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Mouth/Throat/Ears symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">255</enrollment>
  <condition>Rhinitis</condition>
  <arm_group>
    <arm_group_label>loratadine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>fexofenadine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants will receive one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Participants will receive one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>loratadine</intervention_name>
    <description>loratadine, one 10 mg tablet, orally</description>
    <arm_group_label>loratadine</arm_group_label>
    <other_name>SCH 029851</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>fexofenadine</intervention_name>
    <description>fexofenadine, one 180 mg tablet, orally</description>
    <arm_group_label>fexofenadine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo to loratadine</intervention_name>
    <description>one tablet, orally</description>
    <arm_group_label>fexofenadine</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo to fexofenadine</intervention_name>
    <description>one tablet, orally</description>
    <arm_group_label>loratadine</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Female participants of child bearing potential must demonstrate a negative

        urine pregnancy test at Screening (Visit 1) and Visit 4 (prior to randomization) and agree
        to use (and/or have their partner use) 2 acceptable methods of birth control beginning at
        the Screening visit and throughout the study.

          -  Willing to stop use of current decongestant and allergy medications at the start of
             the washout period (Visit 1) and during the trial.

          -  Documented history or participant-reported history of seasonal allergic rhinitis
             caused by mountain cedar pollen within the last 2 years and documented or
             participant-reported symptoms over at least the last 2 mountain cedar allergy
             seasons.

          -  Documented skin testing (prick with wheal â‰¥ 4 mm larger than the diluent) within the
             last 1 year to mountain cedar pollen present.

          -  Capable of reading English.

          -  Body mass index (BMI) &lt;35.

        Exclusion Criteria:

          -  Any significant medical condition which, in the judgment of the investigator, is a
             contraindication to the use of loratadine, fexofenadine or might interfere with the
             trial. These may include thyroid disease (e.g., hyperthyroidism, hypothyroidism),
             uncontrolled diabetes mellitus, coronary heart disease, ischemic heart disease,
             elevated intraocular pressure, prostatic hypertrophy.

          -  Have started allergen immunotherapy within 1 month preceding enrollment or
             participants starting allergen immunotherapy or anticipating immunotherapy dose
             change during the trial. Xolair (omalizumab) may not be used within 4 years prior to
             trial participation.

          -  Known allergy or intolerance to loratadine, desloratadine, or fexofenadine.

          -  History of rhinitis medicamentosa.

          -  Use of systemic (oral, rectal, injectable), topical (up to 1% topical hydrocortisone
             is permitted), or nasal corticosteroids in the last 30 days or current or expected
             use of disallowed medications as listed in the protocol.

          -  Asthma, with the exception of mild intermittent asthma.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>February 2015</verification_date>
  <lastchanged_date>February 20, 2015</lastchanged_date>
  <firstreceived_date>November 8, 2011</firstreceived_date>
  <firstreceived_results_date>February 12, 2013</firstreceived_results_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic, Seasonal</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Fexofenadine</mesh_term>
    <mesh_term>Loratadine</mesh_term>
    <mesh_term>Terfenadine</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Loratadine</title>
          <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="P2">
          <title>Fexofenadine</title>
          <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="P3">
          <title>Placebo</title>
          <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="85"/>
                <participants group_id="P2" count="85"/>
                <participants group_id="P3" count="85"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="85"/>
                <participants group_id="P2" count="85"/>
                <participants group_id="P3" count="85"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Loratadine</title>
          <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="B2">
          <title>Fexofenadine</title>
          <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="B3">
          <title>Placebo</title>
          <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <measure_list>
        <measure>
          <title>Number of Participants</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="85"/>
                <measurement group_id="B2" value="85"/>
                <measurement group_id="B3" value="85"/>
                <measurement group_id="B4" value="255"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <category_list>
            <category>
              <measurement_list>
                <measurement group_id="B1" value="41.5" spread="13.52"/>
                <measurement group_id="B2" value="43.1" spread="12.21"/>
                <measurement group_id="B3" value="40.6" spread="12.56"/>
                <measurement group_id="B4" value="41.7" spread="12.77"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <category_list>
            <category>
              <sub_title>Female</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="51"/>
                <measurement group_id="B2" value="53"/>
                <measurement group_id="B3" value="53"/>
                <measurement group_id="B4" value="157"/>
              </measurement_list>
            </category>
            <category>
              <sub_title>Male</sub_title>
              <measurement_list>
                <measurement group_id="B1" value="34"/>
                <measurement group_id="B2" value="32"/>
                <measurement group_id="B3" value="32"/>
                <measurement group_id="B4" value="98"/>
              </measurement_list>
            </category>
          </category_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Mean Major Symptom Complex (MSC) Score by Post-Treatment Evaluation Time Point (From 180 Minutes to 300 Minutes)</title>
        <description>The MSC Score is calculated as the sum of 5 individual symptom scores for Runny Nose, Itchy Nose, Sneezing, Watery Eyes, and Itchy Eyes. Each individual symptom is rated on a 5-point scale of severity: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The total MSC score ranges from 0 - 25. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Major Symptom Complex (MSC) Score by Post-Treatment Evaluation Time Point (From 180 Minutes to 300 Minutes)</title>
            <description>The MSC Score is calculated as the sum of 5 individual symptom scores for Runny Nose, Itchy Nose, Sneezing, Watery Eyes, and Itchy Eyes. Each individual symptom is rated on a 5-point scale of severity: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The total MSC score ranges from 0 - 25. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>180 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.4" spread="4.51"/>
                  <measurement group_id="O2" value="6.7" spread="4.86"/>
                  <measurement group_id="O3" value="8.5" spread="5.07"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.5" spread="4.84"/>
                  <measurement group_id="O2" value="6.7" spread="4.87"/>
                  <measurement group_id="O3" value="8.9" spread="5.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.3" spread="4.73"/>
                  <measurement group_id="O2" value="6.5" spread="4.87"/>
                  <measurement group_id="O3" value="8.7" spread="5.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.4" spread="4.63"/>
                  <measurement group_id="O2" value="6.5" spread="4.70"/>
                  <measurement group_id="O3" value="8.5" spread="5.36"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes (n=84, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.4" spread="4.76"/>
                  <measurement group_id="O2" value="6.5" spread="4.43"/>
                  <measurement group_id="O3" value="8.3" spread="5.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.1" spread="4.78"/>
                  <measurement group_id="O2" value="6.3" spread="4.47"/>
                  <measurement group_id="O3" value="8.4" spread="5.51"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.0" spread="4.67"/>
                  <measurement group_id="O2" value="6.4" spread="4.50"/>
                  <measurement group_id="O3" value="8.4" spread="5.56"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.3" spread="4.52"/>
                  <measurement group_id="O2" value="6.9" spread="4.76"/>
                  <measurement group_id="O3" value="8.7" spread="5.76"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes (n=84, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="7.1" spread="4.54"/>
                  <measurement group_id="O2" value="6.5" spread="4.65"/>
                  <measurement group_id="O3" value="8.4" spread="5.58"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Score for Runny Nose by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Runny Nose was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Runny Nose symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Score for Runny Nose by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Runny Nose was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Runny Nose symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.4" spread="0.77"/>
                  <measurement group_id="O2" value="3.2" spread="0.78"/>
                  <measurement group_id="O3" value="3.3" spread="0.89"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.1" spread="0.85"/>
                  <measurement group_id="O2" value="3.0" spread="0.91"/>
                  <measurement group_id="O3" value="3.0" spread="1.09"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.0" spread="0.95"/>
                  <measurement group_id="O2" value="2.9" spread="0.99"/>
                  <measurement group_id="O3" value="2.9" spread="1.14"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.8" spread="0.99"/>
                  <measurement group_id="O2" value="2.6" spread="1.05"/>
                  <measurement group_id="O3" value="2.8" spread="1.15"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.7" spread="1.06"/>
                  <measurement group_id="O2" value="2.3" spread="1.02"/>
                  <measurement group_id="O3" value="2.7" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.6" spread="1.06"/>
                  <measurement group_id="O2" value="2.2" spread="1.08"/>
                  <measurement group_id="O3" value="2.6" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.04"/>
                  <measurement group_id="O2" value="2.1" spread="1.08"/>
                  <measurement group_id="O3" value="2.4" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.10"/>
                  <measurement group_id="O2" value="2.1" spread="1.03"/>
                  <measurement group_id="O3" value="2.5" spread="1.16"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.07"/>
                  <measurement group_id="O2" value="2.0" spread="1.00"/>
                  <measurement group_id="O3" value="2.3" spread="1.18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="1.12"/>
                  <measurement group_id="O2" value="2.0" spread="1.07"/>
                  <measurement group_id="O3" value="2.4" spread="1.19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.10"/>
                  <measurement group_id="O2" value="2.0" spread="1.07"/>
                  <measurement group_id="O3" value="2.4" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="1.07"/>
                  <measurement group_id="O2" value="1.8" spread="1.14"/>
                  <measurement group_id="O3" value="2.3" spread="1.18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.20"/>
                  <measurement group_id="O2" value="1.9" spread="1.20"/>
                  <measurement group_id="O3" value="2.3" spread="1.17"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.27"/>
                  <measurement group_id="O2" value="1.9" spread="1.21"/>
                  <measurement group_id="O3" value="2.4" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.23"/>
                  <measurement group_id="O2" value="1.8" spread="1.22"/>
                  <measurement group_id="O3" value="2.3" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.22"/>
                  <measurement group_id="O2" value="1.8" spread="1.24"/>
                  <measurement group_id="O3" value="2.3" spread="1.19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.23"/>
                  <measurement group_id="O2" value="1.8" spread="1.19"/>
                  <measurement group_id="O3" value="2.2" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.30"/>
                  <measurement group_id="O2" value="1.7" spread="1.15"/>
                  <measurement group_id="O3" value="2.3" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.30"/>
                  <measurement group_id="O2" value="1.8" spread="1.10"/>
                  <measurement group_id="O3" value="2.3" spread="1.35"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.24"/>
                  <measurement group_id="O2" value="1.9" spread="1.15"/>
                  <measurement group_id="O3" value="2.3" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.26"/>
                  <measurement group_id="O2" value="1.8" spread="1.14"/>
                  <measurement group_id="O3" value="2.3" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.25"/>
                  <measurement group_id="O2" value="1.8" spread="1.17"/>
                  <measurement group_id="O3" value="2.4" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="1.26"/>
                  <measurement group_id="O2" value="1.8" spread="1.18"/>
                  <measurement group_id="O3" value="2.3" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.27"/>
                  <measurement group_id="O2" value="1.8" spread="1.17"/>
                  <measurement group_id="O3" value="2.4" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.29"/>
                  <measurement group_id="O2" value="1.9" spread="1.23"/>
                  <measurement group_id="O3" value="2.3" spread="1.33"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Score for Itchy Nose by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Itchy Nose was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Nose symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Score for Itchy Nose by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Itchy Nose was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Nose symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.3" spread="0.74"/>
                  <measurement group_id="O2" value="3.3" spread="0.73"/>
                  <measurement group_id="O3" value="3.4" spread="0.77"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.1" spread="0.84"/>
                  <measurement group_id="O2" value="3.2" spread="0.81"/>
                  <measurement group_id="O3" value="3.1" spread="0.93"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.8" spread="0.97"/>
                  <measurement group_id="O2" value="2.8" spread="0.97"/>
                  <measurement group_id="O3" value="2.8" spread="0.99"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.7" spread="1.02"/>
                  <measurement group_id="O2" value="2.6" spread="0.96"/>
                  <measurement group_id="O3" value="2.8" spread="1.04"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.6" spread="1.09"/>
                  <measurement group_id="O2" value="2.4" spread="1.05"/>
                  <measurement group_id="O3" value="2.6" spread="1.07"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.16"/>
                  <measurement group_id="O2" value="2.3" spread="1.14"/>
                  <measurement group_id="O3" value="2.5" spread="1.19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.10"/>
                  <measurement group_id="O2" value="2.1" spread="1.07"/>
                  <measurement group_id="O3" value="2.4" spread="1.17"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="1.08"/>
                  <measurement group_id="O2" value="2.1" spread="1.10"/>
                  <measurement group_id="O3" value="2.4" spread="1.10"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.14"/>
                  <measurement group_id="O2" value="1.8" spread="1.12"/>
                  <measurement group_id="O3" value="2.1" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.12"/>
                  <measurement group_id="O2" value="1.8" spread="1.17"/>
                  <measurement group_id="O3" value="2.2" spread="1.22"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.1" spread="1.06"/>
                  <measurement group_id="O2" value="1.8" spread="1.19"/>
                  <measurement group_id="O3" value="2.2" spread="1.18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.09"/>
                  <measurement group_id="O2" value="1.7" spread="1.22"/>
                  <measurement group_id="O3" value="2.2" spread="1.14"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.16"/>
                  <measurement group_id="O2" value="1.8" spread="1.25"/>
                  <measurement group_id="O3" value="2.2" spread="1.12"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.23"/>
                  <measurement group_id="O2" value="1.7" spread="1.22"/>
                  <measurement group_id="O3" value="2.2" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.25"/>
                  <measurement group_id="O2" value="1.7" spread="1.28"/>
                  <measurement group_id="O3" value="2.2" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.18"/>
                  <measurement group_id="O2" value="1.7" spread="1.27"/>
                  <measurement group_id="O3" value="2.2" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.14"/>
                  <measurement group_id="O2" value="1.7" spread="1.24"/>
                  <measurement group_id="O3" value="2.2" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.24"/>
                  <measurement group_id="O2" value="1.7" spread="1.21"/>
                  <measurement group_id="O3" value="2.2" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.18"/>
                  <measurement group_id="O2" value="1.7" spread="1.25"/>
                  <measurement group_id="O3" value="2.1" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.17"/>
                  <measurement group_id="O2" value="1.8" spread="1.22"/>
                  <measurement group_id="O3" value="2.2" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.19"/>
                  <measurement group_id="O2" value="1.8" spread="1.20"/>
                  <measurement group_id="O3" value="2.1" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.26"/>
                  <measurement group_id="O2" value="1.8" spread="1.22"/>
                  <measurement group_id="O3" value="2.2" spread="1.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.16"/>
                  <measurement group_id="O2" value="1.7" spread="1.25"/>
                  <measurement group_id="O3" value="2.1" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.23"/>
                  <measurement group_id="O2" value="1.7" spread="1.29"/>
                  <measurement group_id="O3" value="2.2" spread="1.36"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.22"/>
                  <measurement group_id="O2" value="1.8" spread="1.32"/>
                  <measurement group_id="O3" value="2.2" spread="1.38"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Scores for Sneezing by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Sneezing was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Sneezing symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Scores for Sneezing by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Sneezing was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Sneezing symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="1.37"/>
                  <measurement group_id="O2" value="1.2" spread="1.36"/>
                  <measurement group_id="O3" value="1.5" spread="1.40"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.31"/>
                  <measurement group_id="O2" value="1.2" spread="1.39"/>
                  <measurement group_id="O3" value="1.3" spread="1.37"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.34"/>
                  <measurement group_id="O2" value="1.1" spread="1.32"/>
                  <measurement group_id="O3" value="1.2" spread="1.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.0" spread="1.29"/>
                  <measurement group_id="O2" value="0.9" spread="1.22"/>
                  <measurement group_id="O3" value="1.3" spread="1.39"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.1" spread="1.21"/>
                  <measurement group_id="O2" value="0.7" spread="1.12"/>
                  <measurement group_id="O3" value="1.2" spread="1.36"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.0" spread="1.25"/>
                  <measurement group_id="O2" value="0.8" spread="1.16"/>
                  <measurement group_id="O3" value="1.1" spread="1.39"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.12"/>
                  <measurement group_id="O2" value="0.6" spread="1.07"/>
                  <measurement group_id="O3" value="1.0" spread="1.37"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.16"/>
                  <measurement group_id="O2" value="0.6" spread="1.07"/>
                  <measurement group_id="O3" value="1.1" spread="1.43"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.5" spread="0.88"/>
                  <measurement group_id="O2" value="0.5" spread="1.04"/>
                  <measurement group_id="O3" value="0.9" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.13"/>
                  <measurement group_id="O2" value="0.7" spread="1.20"/>
                  <measurement group_id="O3" value="1.2" spread="1.48"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.9" spread="1.22"/>
                  <measurement group_id="O2" value="0.6" spread="1.14"/>
                  <measurement group_id="O3" value="1.1" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.11"/>
                  <measurement group_id="O2" value="0.5" spread="1.03"/>
                  <measurement group_id="O3" value="0.9" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.08"/>
                  <measurement group_id="O2" value="0.6" spread="1.11"/>
                  <measurement group_id="O3" value="0.9" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.19"/>
                  <measurement group_id="O2" value="0.6" spread="1.09"/>
                  <measurement group_id="O3" value="1.0" spread="1.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.07"/>
                  <measurement group_id="O2" value="0.5" spread="1.03"/>
                  <measurement group_id="O3" value="1.0" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.04"/>
                  <measurement group_id="O2" value="0.6" spread="0.93"/>
                  <measurement group_id="O3" value="0.9" spread="1.33"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.09"/>
                  <measurement group_id="O2" value="0.5" spread="1.04"/>
                  <measurement group_id="O3" value="0.9" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="1.15"/>
                  <measurement group_id="O2" value="0.4" spread="0.86"/>
                  <measurement group_id="O3" value="1.0" spread="1.41"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="1.13"/>
                  <measurement group_id="O2" value="0.5" spread="1.00"/>
                  <measurement group_id="O3" value="1.0" spread="1.40"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.8" spread="1.08"/>
                  <measurement group_id="O2" value="0.6" spread="1.07"/>
                  <measurement group_id="O3" value="1.1" spread="1.42"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes (n=84, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.02"/>
                  <measurement group_id="O2" value="0.5" spread="0.95"/>
                  <measurement group_id="O3" value="0.9" spread="1.34"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes (n=84, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.10"/>
                  <measurement group_id="O2" value="0.4" spread="0.94"/>
                  <measurement group_id="O3" value="1.1" spread="1.40"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.02"/>
                  <measurement group_id="O2" value="0.6" spread="1.03"/>
                  <measurement group_id="O3" value="1.0" spread="1.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes (n=84, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.7" spread="1.09"/>
                  <measurement group_id="O2" value="0.6" spread="0.99"/>
                  <measurement group_id="O3" value="1.0" spread="1.33"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="0.6" spread="1.12"/>
                  <measurement group_id="O2" value="0.6" spread="1.09"/>
                  <measurement group_id="O3" value="1.0" spread="1.38"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Scores for Watery Eyes by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Water Eyes was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Watery Eyes symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Scores for Watery Eyes by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Water Eyes was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Watery Eyes symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.7" spread="1.12"/>
                  <measurement group_id="O2" value="2.8" spread="1.05"/>
                  <measurement group_id="O3" value="2.7" spread="1.02"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.17"/>
                  <measurement group_id="O2" value="2.6" spread="1.10"/>
                  <measurement group_id="O3" value="2.4" spread="1.15"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="1.23"/>
                  <measurement group_id="O2" value="2.3" spread="1.17"/>
                  <measurement group_id="O3" value="2.1" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.22"/>
                  <measurement group_id="O2" value="2.0" spread="1.19"/>
                  <measurement group_id="O3" value="2.0" spread="1.18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.21"/>
                  <measurement group_id="O2" value="1.9" spread="1.16"/>
                  <measurement group_id="O3" value="1.9" spread="1.12"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.7" spread="1.21"/>
                  <measurement group_id="O2" value="1.8" spread="1.19"/>
                  <measurement group_id="O3" value="1.6" spread="1.11"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.29"/>
                  <measurement group_id="O2" value="1.6" spread="1.23"/>
                  <measurement group_id="O3" value="1.5" spread="1.18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.22"/>
                  <measurement group_id="O2" value="1.6" spread="1.13"/>
                  <measurement group_id="O3" value="1.5" spread="1.19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="1.15"/>
                  <measurement group_id="O2" value="1.3" spread="1.09"/>
                  <measurement group_id="O3" value="1.4" spread="1.18"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.11"/>
                  <measurement group_id="O2" value="1.3" spread="1.11"/>
                  <measurement group_id="O3" value="1.4" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.12"/>
                  <measurement group_id="O2" value="1.2" spread="1.19"/>
                  <measurement group_id="O3" value="1.4" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.14"/>
                  <measurement group_id="O2" value="1.2" spread="1.14"/>
                  <measurement group_id="O3" value="1.4" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.07"/>
                  <measurement group_id="O2" value="1.1" spread="1.12"/>
                  <measurement group_id="O3" value="1.3" spread="1.16"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.15"/>
                  <measurement group_id="O2" value="1.2" spread="1.19"/>
                  <measurement group_id="O3" value="1.5" spread="1.21"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.14"/>
                  <measurement group_id="O2" value="1.1" spread="1.13"/>
                  <measurement group_id="O3" value="1.4" spread="1.27"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.13"/>
                  <measurement group_id="O2" value="1.1" spread="1.16"/>
                  <measurement group_id="O3" value="1.4" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.16"/>
                  <measurement group_id="O2" value="1.1" spread="1.10"/>
                  <measurement group_id="O3" value="1.4" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.12"/>
                  <measurement group_id="O2" value="1.1" spread="1.13"/>
                  <measurement group_id="O3" value="1.4" spread="1.26"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.13"/>
                  <measurement group_id="O2" value="1.1" spread="1.09"/>
                  <measurement group_id="O3" value="1.4" spread="1.21"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.08"/>
                  <measurement group_id="O2" value="1.2" spread="1.13"/>
                  <measurement group_id="O3" value="1.4" spread="1.27"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.02"/>
                  <measurement group_id="O2" value="1.1" spread="1.10"/>
                  <measurement group_id="O3" value="1.3" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.09"/>
                  <measurement group_id="O2" value="1.2" spread="1.13"/>
                  <measurement group_id="O3" value="1.4" spread="1.33"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="1.14"/>
                  <measurement group_id="O2" value="1.2" spread="1.15"/>
                  <measurement group_id="O3" value="1.4" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.15"/>
                  <measurement group_id="O2" value="1.2" spread="1.19"/>
                  <measurement group_id="O3" value="1.4" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.2" spread="1.20"/>
                  <measurement group_id="O2" value="1.3" spread="1.17"/>
                  <measurement group_id="O3" value="1.4" spread="1.34"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Scores for Itchy Eyes by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Itchy Eyes was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Eyes symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Scores for Itchy Eyes by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Itchy Eyes was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Eyes symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.0" spread="0.93"/>
                  <measurement group_id="O2" value="3.2" spread="0.87"/>
                  <measurement group_id="O3" value="3.1" spread="1.08"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes (n=85, n=85, n=84)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.6" spread="1.10"/>
                  <measurement group_id="O2" value="3.0" spread="1.02"/>
                  <measurement group_id="O3" value="2.8" spread="1.15"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.12"/>
                  <measurement group_id="O2" value="2.7" spread="1.17"/>
                  <measurement group_id="O3" value="2.4" spread="1.20"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.2" spread="1.14"/>
                  <measurement group_id="O2" value="2.3" spread="1.17"/>
                  <measurement group_id="O3" value="2.4" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.14"/>
                  <measurement group_id="O2" value="2.1" spread="1.14"/>
                  <measurement group_id="O3" value="2.2" spread="1.23"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.14"/>
                  <measurement group_id="O2" value="2.0" spread="1.20"/>
                  <measurement group_id="O3" value="1.9" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.21"/>
                  <measurement group_id="O2" value="1.8" spread="1.17"/>
                  <measurement group_id="O3" value="1.9" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.18"/>
                  <measurement group_id="O2" value="1.8" spread="1.15"/>
                  <measurement group_id="O3" value="1.8" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.19"/>
                  <measurement group_id="O2" value="1.6" spread="1.14"/>
                  <measurement group_id="O3" value="1.7" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.14"/>
                  <measurement group_id="O2" value="1.5" spread="1.13"/>
                  <measurement group_id="O3" value="1.7" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.06"/>
                  <measurement group_id="O2" value="1.4" spread="1.20"/>
                  <measurement group_id="O3" value="1.6" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.11"/>
                  <measurement group_id="O2" value="1.4" spread="1.24"/>
                  <measurement group_id="O3" value="1.7" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.11"/>
                  <measurement group_id="O2" value="1.4" spread="1.18"/>
                  <measurement group_id="O3" value="1.7" spread="1.23"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.15"/>
                  <measurement group_id="O2" value="1.4" spread="1.19"/>
                  <measurement group_id="O3" value="1.8" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.12"/>
                  <measurement group_id="O2" value="1.4" spread="1.21"/>
                  <measurement group_id="O3" value="1.7" spread="1.26"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.15"/>
                  <measurement group_id="O2" value="1.4" spread="1.19"/>
                  <measurement group_id="O3" value="1.7" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes (n=84, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.19"/>
                  <measurement group_id="O2" value="1.4" spread="1.11"/>
                  <measurement group_id="O3" value="1.7" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.13"/>
                  <measurement group_id="O2" value="1.4" spread="1.18"/>
                  <measurement group_id="O3" value="1.6" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.09"/>
                  <measurement group_id="O2" value="1.4" spread="1.15"/>
                  <measurement group_id="O3" value="1.6" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.3" spread="1.16"/>
                  <measurement group_id="O2" value="1.4" spread="1.17"/>
                  <measurement group_id="O3" value="1.7" spread="1.42"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.19"/>
                  <measurement group_id="O2" value="1.4" spread="1.18"/>
                  <measurement group_id="O3" value="1.7" spread="1.33"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.19"/>
                  <measurement group_id="O2" value="1.4" spread="1.24"/>
                  <measurement group_id="O3" value="1.7" spread="1.36"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.21"/>
                  <measurement group_id="O2" value="1.4" spread="1.24"/>
                  <measurement group_id="O3" value="1.6" spread="1.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.23"/>
                  <measurement group_id="O2" value="1.4" spread="1.27"/>
                  <measurement group_id="O3" value="1.8" spread="1.38"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.34"/>
                  <measurement group_id="O2" value="1.4" spread="1.25"/>
                  <measurement group_id="O3" value="1.7" spread="1.37"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Scores for Nasal Congestion by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Nasal Congestion was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Nasal Congestion symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Scores for Nasal Congestion by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Nasal Congestion was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Nasal Congestion symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.4" spread="0.81"/>
                  <measurement group_id="O2" value="3.2" spread="0.88"/>
                  <measurement group_id="O3" value="3.4" spread="0.76"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.5" spread="1.20"/>
                  <measurement group_id="O2" value="2.2" spread="1.25"/>
                  <measurement group_id="O3" value="2.7" spread="1.19"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.33"/>
                  <measurement group_id="O2" value="1.5" spread="1.19"/>
                  <measurement group_id="O3" value="2.0" spread="1.26"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.5" spread="1.16"/>
                  <measurement group_id="O2" value="2.1" spread="1.21"/>
                  <measurement group_id="O3" value="2.6" spread="1.22"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.29"/>
                  <measurement group_id="O2" value="1.4" spread="1.20"/>
                  <measurement group_id="O3" value="1.8" spread="1.34"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.25"/>
                  <measurement group_id="O2" value="2.1" spread="1.21"/>
                  <measurement group_id="O3" value="2.6" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.27"/>
                  <measurement group_id="O2" value="1.3" spread="1.19"/>
                  <measurement group_id="O3" value="1.8" spread="1.34"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.24"/>
                  <measurement group_id="O2" value="2.1" spread="1.20"/>
                  <measurement group_id="O3" value="2.6" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.26"/>
                  <measurement group_id="O2" value="1.4" spread="1.17"/>
                  <measurement group_id="O3" value="1.8" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.24"/>
                  <measurement group_id="O2" value="2.1" spread="1.19"/>
                  <measurement group_id="O3" value="2.6" spread="1.26"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.31"/>
                  <measurement group_id="O2" value="1.3" spread="1.19"/>
                  <measurement group_id="O3" value="1.8" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.26"/>
                  <measurement group_id="O2" value="2.0" spread="1.14"/>
                  <measurement group_id="O3" value="2.5" spread="1.33"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.22"/>
                  <measurement group_id="O2" value="1.3" spread="1.22"/>
                  <measurement group_id="O3" value="1.8" spread="1.39"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.5" spread="1.21"/>
                  <measurement group_id="O2" value="2.0" spread="1.15"/>
                  <measurement group_id="O3" value="2.6" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.31"/>
                  <measurement group_id="O2" value="1.3" spread="1.20"/>
                  <measurement group_id="O3" value="1.8" spread="1.34"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.21"/>
                  <measurement group_id="O2" value="2.0" spread="1.24"/>
                  <measurement group_id="O3" value="2.6" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.29"/>
                  <measurement group_id="O2" value="1.4" spread="1.21"/>
                  <measurement group_id="O3" value="1.8" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes (n=85, n=85, n=84)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.26"/>
                  <measurement group_id="O2" value="2.0" spread="1.19"/>
                  <measurement group_id="O3" value="2.6" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes (n=85, n=85, n=84)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.29"/>
                  <measurement group_id="O2" value="1.3" spread="1.22"/>
                  <measurement group_id="O3" value="1.8" spread="1.46"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.31"/>
                  <measurement group_id="O2" value="2.1" spread="1.19"/>
                  <measurement group_id="O3" value="2.6" spread="1.34"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.31"/>
                  <measurement group_id="O2" value="1.3" spread="1.25"/>
                  <measurement group_id="O3" value="1.8" spread="1.43"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.29"/>
                  <measurement group_id="O2" value="2.1" spread="1.19"/>
                  <measurement group_id="O3" value="2.5" spread="1.39"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.31"/>
                  <measurement group_id="O2" value="1.3" spread="1.24"/>
                  <measurement group_id="O3" value="1.8" spread="1.47"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.28"/>
                  <measurement group_id="O2" value="2.0" spread="1.24"/>
                  <measurement group_id="O3" value="2.5" spread="1.33"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.31"/>
                  <measurement group_id="O2" value="1.4" spread="1.31"/>
                  <measurement group_id="O3" value="1.9" spread="1.51"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Mean Individual Symptom Scores for Itchy Mouth/Throat/Ears by Post-Treatment Evaluation Time Point</title>
        <description>The individual symptom score for Itchy Mouth/Throat/Ears was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Mouth/Throat/Ears symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
        <time_frame>From time of sensitization (time 0) to end of visit (~8 hours)</time_frame>
        <safety_issue>No</safety_issue>
        <population>Participants in the Intent-to-Treat (ITT) Population (defined as all participants who successfully exhibited appropriate sensitivity and were randomized to study treatment) who had data available.
N=Number of Participants Analyzed, n=number of participants with data available at the given time point.</population>
        <group_list>
          <group group_id="O1">
            <title>Loratadine</title>
            <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O2">
            <title>Fexofenadine</title>
            <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
          <group group_id="O3">
            <title>Placebo</title>
            <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
          </group>
        </group_list>
        <measure_list>
          <measure>
            <title>Number of Participants</title>
            <units>participants</units>
            <param>Number</param>
            <category_list>
              <category>
                <measurement_list>
                  <measurement group_id="O1" value="85"/>
                  <measurement group_id="O2" value="85"/>
                  <measurement group_id="O3" value="85"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
          <measure>
            <title>Mean Individual Symptom Scores for Itchy Mouth/Throat/Ears by Post-Treatment Evaluation Time Point</title>
            <description>The individual symptom score for Itchy Mouth/Throat/Ears was rated on a 5-point
scale of severity using the following scale: 0 = None (No symptoms), 1 = MILD (Symptom is present, but easily tolerated), 2 = MODERATE (Awareness of symptoms, bothersome, but tolerable), 3 = SEVERE (Definite awareness of symptoms, difficult to tolerate but does not interfere with activities), 4 = VERY SEVERE (Difficult to tolerate and interferes with the activities of daily living). The Itchy Mouth/Throat/Ears symptom score ranges from 0 - 5. Increasing scores are associated with increasing severity.</description>
            <units>units on a scale</units>
            <param>Mean</param>
            <dispersion>Standard Deviation</dispersion>
            <category_list>
              <category>
                <sub_title>0 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.0" spread="1.08"/>
                  <measurement group_id="O2" value="3.0" spread="1.05"/>
                  <measurement group_id="O3" value="2.9" spread="1.17"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>15 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.2" spread="1.05"/>
                  <measurement group_id="O2" value="3.0" spread="1.06"/>
                  <measurement group_id="O3" value="3.0" spread="1.09"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>30 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.6" spread="1.19"/>
                  <measurement group_id="O2" value="2.8" spread="1.17"/>
                  <measurement group_id="O3" value="2.6" spread="1.27"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>45 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="3.0" spread="1.11"/>
                  <measurement group_id="O2" value="2.8" spread="1.09"/>
                  <measurement group_id="O3" value="2.8" spread="1.06"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>60 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.29"/>
                  <measurement group_id="O2" value="2.6" spread="1.27"/>
                  <measurement group_id="O3" value="2.4" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>75 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.8" spread="1.16"/>
                  <measurement group_id="O2" value="2.6" spread="1.16"/>
                  <measurement group_id="O3" value="2.8" spread="1.12"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>90 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.0" spread="1.22"/>
                  <measurement group_id="O2" value="2.3" spread="1.16"/>
                  <measurement group_id="O3" value="2.3" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>105 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.7" spread="1.19"/>
                  <measurement group_id="O2" value="2.4" spread="1.17"/>
                  <measurement group_id="O3" value="2.6" spread="1.14"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>120 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.9" spread="1.24"/>
                  <measurement group_id="O2" value="2.0" spread="1.15"/>
                  <measurement group_id="O3" value="2.1" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>135 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.6" spread="1.20"/>
                  <measurement group_id="O2" value="2.3" spread="1.24"/>
                  <measurement group_id="O3" value="2.5" spread="1.24"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>150 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.8" spread="1.21"/>
                  <measurement group_id="O2" value="1.8" spread="1.17"/>
                  <measurement group_id="O3" value="1.9" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>165 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.5" spread="1.17"/>
                  <measurement group_id="O2" value="2.2" spread="1.21"/>
                  <measurement group_id="O3" value="2.4" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>180 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.7" spread="1.20"/>
                  <measurement group_id="O2" value="1.7" spread="1.21"/>
                  <measurement group_id="O3" value="1.8" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>195 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.25"/>
                  <measurement group_id="O2" value="2.1" spread="1.17"/>
                  <measurement group_id="O3" value="2.4" spread="1.26"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>210 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.6" spread="1.21"/>
                  <measurement group_id="O2" value="1.7" spread="1.12"/>
                  <measurement group_id="O3" value="1.9" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>225 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.13"/>
                  <measurement group_id="O2" value="2.0" spread="1.20"/>
                  <measurement group_id="O3" value="2.3" spread="1.25"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>240 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.18"/>
                  <measurement group_id="O2" value="1.5" spread="1.15"/>
                  <measurement group_id="O3" value="1.7" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>255 minutes (n=85, n=85, n=84)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.19"/>
                  <measurement group_id="O2" value="2.0" spread="1.22"/>
                  <measurement group_id="O3" value="2.4" spread="1.28"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>270 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.20"/>
                  <measurement group_id="O2" value="1.6" spread="1.16"/>
                  <measurement group_id="O3" value="1.7" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>285 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.16"/>
                  <measurement group_id="O2" value="2.0" spread="1.26"/>
                  <measurement group_id="O3" value="2.4" spread="1.31"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>300 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.5" spread="1.14"/>
                  <measurement group_id="O2" value="1.4" spread="1.21"/>
                  <measurement group_id="O3" value="1.8" spread="1.32"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>315 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.4" spread="1.18"/>
                  <measurement group_id="O2" value="2.0" spread="1.23"/>
                  <measurement group_id="O3" value="2.4" spread="1.30"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>330 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.19"/>
                  <measurement group_id="O2" value="1.4" spread="1.22"/>
                  <measurement group_id="O3" value="1.7" spread="1.23"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>345 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="2.3" spread="1.20"/>
                  <measurement group_id="O2" value="2.0" spread="1.25"/>
                  <measurement group_id="O3" value="2.5" spread="1.29"/>
                </measurement_list>
              </category>
              <category>
                <sub_title>360 minutes (n=85, n=85, n=85)</sub_title>
                <measurement_list>
                  <measurement group_id="O1" value="1.4" spread="1.17"/>
                  <measurement group_id="O2" value="1.3" spread="1.21"/>
                  <measurement group_id="O3" value="1.7" spread="1.27"/>
                </measurement_list>
              </category>
            </category_list>
          </measure>
        </measure_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Loratadine</title>
          <description>Participants received one dose of loratadine following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="E2">
          <title>Fexofenadine</title>
          <description>Participants received one dose of fexofenadine following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
        <group group_id="E3">
          <title>Placebo</title>
          <description>Participants received one dose of placebo following randomization at 120 minutes of exposure during visit 4.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="85"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="85"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="85"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Senior Vice President, Global Clinical Development</name_or_title>
      <organization>Merck Sharp &amp; Dohme Corp.</organization>
      <email>ClinicalTrialsDisclosure@merck.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>
